PCOS has a new name, and the internet has a lot of opinions about why.


It's called PMOS now. Polyendocrine metabolic ovarian syndrome. Returning guest Julie Duffy Dillon joins me to break down what changed, what didn't, and what the research actually shows about GLP-1 medications and PCOS beyond weight loss.


In this episode, you'll learn:

  • Why PCOS was renamed PMOS after more than a decade of research
  • What the name change does and doesn't change about your care
  • What the research shows about GLP-1s and PCOS insulin resistance, triglycerides, and androgens
  • Why insurance mostly covers the wrong dose, and who that leaves behind
  • What to do when your provider starts talking about your weight again


Mentioned in the show:

Beyond GLP-1 Expert Podcast Series: https://program.stephaniedodier.com/beyond-glp-1

Julie's Substack: https://findyourfoodvoice.substack.com/

Coach Corner Vault: https://www.stephaniedodier.com/coach-corner/

Non-Diet Client Assessment Tool: https://www.stephaniedodier.com/clientassessment

Non-Diet Coaching Certification Waitlist: https://www.stephaniedodier.com/non-diet-coaching-certification/

Groundwork: https://www.stephaniedodier.com/groundwork

Podden och tillhörande omslagsbild på den här sidan tillhör Stephanie Dodier. Innehållet i podden är skapat av Stephanie Dodier och inte av, eller tillsammans med, Poddtoppen.